MREO
Mereo BioPharma
MREO
MREO
56 hedge funds and large institutions have $90.4M invested in Mereo BioPharma in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.27% less ownership
Funds ownership: 10.32% → 10.06% (-0.27%)
13% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 15
Holders
56
Holding in Top 10
–
Calls
$680K
Puts
$19K
Top Buyers
| 1 | +$12.5M | |
| 2 | +$1.49M | |
| 3 | +$1.03M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$818K |
| 5 |
6CM
683 Capital Management
New York
|
+$774K |
Top Sellers
| 1 | -$4.69M | |
| 2 | -$2.97M | |
| 3 | -$221K | |
| 4 |
PFMU
Privium Fund Management (UK)
London,
United Kingdom
|
-$200K |
| 5 |
MAM
Monaco Asset Management
Monaco
|
-$142K |